Jung Won Beom, Kim Chan Wook, Kim Jin Cheon
Department of Surgery, Institute of Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Cancer Res Treat. 2014 Oct;46(4):366-73. doi: 10.4143/crt.2013.185. Epub 2014 Aug 25.
The objective of this study was to examine the clincopathologic characteristics and outcomes of familial adenomatous polyposis (FAP) patients with and without desmoid tumors (DTs), including the risk factors for progression of FAP-related DTs.
We reviewed the medical records and database of all patients with FAP who were treated between January 1993 and December 2011.
Of 75 FAP patients, 18 (24%) were FAP with DTs. Seventeen of these had intra-abdominal DTs and one had intra- and extra-abdominal DTs. We divided the patients into two groups according to type of resection; the R0 or R1 resection group, referred to as the curative resection group (eight patients), and the R2 resection/palliative operation/medical treatment group, referred to as the palliative resection group (10 patients). Two patients in the curative resection group and two patients in the palliative group had progressed to tumor growth by the follow-up (p=0.800). In univariate analysis, DT diagnosis before or simultaneously with FAP diagnosis (DTs unrelated to surgical trauma) was a significant risk factor for tumor progression at final follow-up.
A multidisciplinary approach to DT treatment is needed, including nonsteroidal antiinflammatory drugs, anti-estrogens, cytotoxic agents, and surgery. However, the role of surgery in resectable and complicated tumors may be limited. DT unrelated to surgical trauma has a relatively poor prognosis.
本研究的目的是检查有或没有硬纤维瘤(DTs)的家族性腺瘤性息肉病(FAP)患者的临床病理特征和预后,包括FAP相关DTs进展的危险因素。
我们回顾了1993年1月至2011年12月期间接受治疗的所有FAP患者的病历和数据库。
75例FAP患者中,18例(24%)为合并DTs的FAP。其中17例有腹内DTs,1例有腹内和腹外DTs。我们根据切除类型将患者分为两组;R0或R1切除组,称为根治性切除组(8例患者),以及R2切除/姑息性手术/药物治疗组,称为姑息性切除组(10例患者)。根治性切除组的2例患者和姑息性组的2例患者在随访时肿瘤进展(p = 0.800)。单因素分析中,在FAP诊断之前或同时诊断的DTs(与手术创伤无关的DTs)是最终随访时肿瘤进展的显著危险因素。
DT治疗需要多学科方法,包括非甾体抗炎药、抗雌激素、细胞毒性药物和手术。然而,手术在可切除和复杂肿瘤中的作用可能有限。与手术创伤无关的DTs预后相对较差。